Carotid Artery Analysis During an LPEC Manoeuvre

Sponsor
University of Liege (Other)
Overall Status
Completed
CT.gov ID
NCT04173910
Collaborator
(none)
50
1
1.5
32.4

Study Details

Study Description

Brief Summary

Verify in ultrasound the impact of a Sellick and LPEC manoeuvre in terms of compression of the carotid artery and decrease in vascular flow.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ultrasound LPEC/Sellick

Study Design

Study Type:
Observational
Actual Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Effect of the Left Paratracheal Compression of the Cervical Esophagus and the Sellick Manoeuvre on the Compressibility of the Carotid Artery and Its Possible Effects on the Vascular Flow
Actual Study Start Date :
Jun 15, 2020
Actual Primary Completion Date :
Jul 15, 2020
Actual Study Completion Date :
Aug 1, 2020

Arms and Interventions

Arm Intervention/Treatment
LPEC/Sellick ultrasound

Procedure: Ultrasound LPEC/Sellick
We will perform an ultrasound of the carotid artery and then apply a Sellick manoeuvre and a left paratracheal compression of the cervical esophagus respectively.

Outcome Measures

Primary Outcome Measures

  1. Compression of the carotid artery during an esophageal compression manoeuvre [through study completion, an average of 1 month]

    Measurement of the diameter of the carotid artery in cross-section and longitudinal section

  2. Vascular flow of the carotid artery during an esophageal compression manoeuvre [through study completion, an average of 1 month]

    Measurement of systolic velocities in pulsed Doppler in the carotid artery

Secondary Outcome Measures

  1. Measurement of the force to be applied to compress the esophagus without compressing the carotid artery [through study completion, an average of 1 month]

    use of a dynamometer to measure the force required to exert at the left paratracheal level

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Adults Volunteers
Exclusion Criteria:
  • pregnant women

  • people with carotid artery defects

  • people with an anomaly in the oropharyngeal massif

Contacts and Locations

Locations

Site City State Country Postal Code
1 Javillier Liège Belgium 4000

Sponsors and Collaborators

  • University of Liege

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Benjamin Javillier, Principal Investigator, University of Liege
ClinicalTrials.gov Identifier:
NCT04173910
Other Study ID Numbers:
  • LPECarotide
First Posted:
Nov 22, 2019
Last Update Posted:
Oct 6, 2020
Last Verified:
Oct 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 6, 2020